News - Baxter


Current filters:


Popular Filters

Baxter posts 10.8% drop in 2nd-qtr earnings but sales grew 3%


USA-based Baxter International (NYSE: BAX) reported financial results for the second quarter of 2013,…

BaxterFinancialHyQviaNorth AmericaPharmaceutical

Baxter and Halozyme's HyQvia approved in European Union


USA-based Baxter International (NYSE: BAX) and Halozyme Therapeutics (Nasdaq: HALO) say that the European…

BaxterBiotechnologyEuropeHalozyme TherapeuticsHyQviaImmunologicalsPharmaceuticalRegulation

World's first long-lasting hemophilia therapies will see Biogen move ahead of Pfizer and Baxter


As US biotech company Biogen Idec (Nasdaq: BIIB) prepares to break into the hemophilia market by launching…

BaxterBiogen IdecBiotechnologyMarkets & MarketingPfizerPharmaceutical

Study attacks Pharma business practices in Brazil


A study reported by broadcaster Deutsche Welle on the business practices of drug companies Bayer, Baxter…

BaxterBayerBoehringer IngelheimMarkets & MarketingPharmaceuticalPricingSouth America

Back to top